Atlas Trials

Evolus, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Evolus, Inc.

RecordFirmDate
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines (NCT05481931)Evolus, Inc.2023-03-15
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines (NCT05320393)Evolus, Inc.2022-03-30
Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 (NCT02428608)Evolus, Inc.2015-05-01
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001 (NCT02334423)Evolus, Inc.2015-01-01
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 (NCT02334436)Evolus, Inc.2015-01-01
Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines (NCT02184988)Evolus, Inc.2014-08-01

Track Evolus, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.